The effects of homocysteine-lowering vitamin supplementation on migraine disability

Completed

• Conditions: Migraine with aura; Nervous System Diseases

• Registration Number: ISRCTN34931928
• Lead Sponsor: Griffith University (Australia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-12-18
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Current diagnosis of regular migraine with aura attacks
2. >18 and <70 years old

Exclusion Criteria

1. Co-morbid vascular or neuropsychiatric disease
2. Pregnant
3. Currently taking B vitamins

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Migraine disability, as measured using the Migraine Disability Assessment (MIDAS) score at baseline and 6 months.

Secondary Outcome Measures

Name	Time	Method
1. Migraine frequency. Duration of follow-up: 6 months<br>2. Migraine pain: MIDAS pain score 1-10 (10 = most severe) at baseline and 6 months